All News

Labels on all extended-release and long-acting opioid analgesics will be amended to ensure they are used only by those who need them and to warn pregnant women of the risk of neonatal narcotic withdrawal syndrome.

A recent trial supports noninferiority of pazopanib and sunitinib in terms of efficacy, with fewer adverse events associated with patient discomfort occurring with pazopanib than with sunitinib.

Inflectra was approved for treatment of inflammatory conditions by the European Medicines Agency based on evidence that it was as effective, safe, and tolerable as its reference drug, Remicade.

A child's risk of developing pertussis increased along with the number of doses of the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine he or she had missed, a study finds.

This fall brings the final season of the series "Breaking Bad," and a recipe for a mouth-watering-and perfectly legal-form of crystal.

Survival rates are generally quite high for the second-most-common cancer among men in the United States.

UHC, an alliance of the nation's leading nonprofit academic medical centers, is unveiling a new specialty pharmacy program in late 2013/early 2014 to provide patients with access to the specialty medications they need at the hospitals where they are treated.

A review of previous studies finds that children with chronic conditions who fail to take their medications as prescribed are more likely to visit the emergency department and be hospitalized.

President Obama recently suggested that law school be shortened by a year. Could a similar proposal to shorten the length of pharmacy school take flight?

The chain's pharmacies stopped filling prescriptions for controlled substances written by 36 physicians it had identified as inappropriate prescribers.

Magellan Health Services Inc. announced it has entered into an agreement to acquire Partners Rx, a privately held, full-service commercial pharmacy benefits management company for $100 million.

New online learning tools aim to educate users about crucial pharmaceutical industry topics in 45 minutes or less.

The report found that use of the sleep aids was more common among women, those who were older, and those who had attained more education.

A range of pharmacy tasks can be handled more efficiently through the use of technology, freeing up pharmacists to spend time helping patients.

Goals for several vaccines recommended for adolescents are in sight or have been met, but coverage with the HPV vaccine continues to lag behind, a CDC report finds.

URAC, an independent accreditation organization advancing quality and value throughout health care, announced the launch of 2 new accreditation programs for Clinical Integration and Accountable Care to address the changing healthcare landscape.

Patients with or at high risk for cardiovascular disease who took a pill that combined aspirin, a statin, and 2 antihypertensives had significantly higher adherence levels than those who received usual care.

Study participants aged 40 to 64 who had received a flu shot had a risk of heart attack reduced by 45%.

Reports from the United States and Europe reference the lack of long-term effectiveness studies and the lack of comparative effectiveness studies as challenges in determining the most appropriate initial biologic disease-modifying antirheumatic drug (DMARD) treatment for patients with rheumatoid arthritis.

Nurses have had success in advancing their professional role and image. What can pharmacists learn from their example?

Chronic comorbid conditions are common in adult asthma patients, and these patients need ongoing support and encouragement from health care providers including pharmacists.

As pharmacogenomics continues to progress, specialty pharmacists may dominate treatment for certain diseases.

A program in which high-risk individuals were offered HIV testing and follow-up support at community pharmacies produced high rates of participation and satisfaction.

The National Psoriasis Foundation Medical Board released a statement supporting the prohibition of biosimilar substitution pending the fulfillment of 7 key measures.